Related Experiment Video
Updated: Jun 19, 2026
Magnetic Fluorescent Bead-Based Dual-Reporter Flow Analysis of PDL1-Vaxx Peptide Vaccine-Induced Antibody Blockade of the PD-1/PD-L1 Interaction
Published on: July 7, 2023
Obstacles to and opportunities for more effective peptide-based therapeutic immunization in human melanoma
Swagatam Ray1, Arvind Chhabra, Shikhar Mehrotra
1Department of Medicine, University of Connecticut Health Center, 263 Farmington Avenue, L-3080, Farmington, CT 06030, USA.
Abstract:
Melanoma cells can play a number of tricks to evade the host immune response. They can make themselves invisible to cells of the immune system poised to attack them, elaborate molecules that are frankly immunosuppressive, and can create a microenvironment that is hostile to cells of the immune system. Efforts are underway to institute measures that would make tumor cells more susceptible to immune attack, but these efforts have not been all that successful so far. This contribution reviews the history and the rationale of cancer vaccines, the major obstacles to peptide-based immunization, and a discussion on how to surmount them. Also included are the roles played by peripheral tolerance, low-affinity T-cell receptors, T-cell ignorance, activation-induced cell death, exhaustion of T cells and regulation of the immune response, helpless cytolytic T lymphocytes, and evasion by tumor cells.
Insights
Melanoma cells employ sophisticated strategies to evade immune detection and attack. Overcoming these tumor evasion tactics is crucial for developing effective cancer vaccines and therapies.
Area of Science:
- Immunology
- Oncology
- Vaccinology
Background:
- Melanoma cells exhibit multiple mechanisms to evade host immune responses, including invisibility, immunosuppression, and creation of hostile microenvironments.
- Current strategies to enhance immune attack susceptibility in tumor cells have limited success.
Purpose of the Study:
- To review the history and rationale behind cancer vaccines.
- To discuss major obstacles in peptide-based immunization and strategies to overcome them.
- To explore various immune evasion mechanisms employed by tumor cells.
Main Methods:
- Literature review of cancer vaccines, immunotherapy, and tumor immune evasion.
- Analysis of historical and current approaches in cancer vaccine development.
- Discussion of immunological factors influencing vaccine efficacy.
Main Results:
- Cancer vaccines face significant hurdles, including peripheral tolerance, T-cell receptor affinity, T-cell ignorance, and activation-induced cell death.
- Tumor cells actively regulate the immune response through mechanisms like T-cell exhaustion and the creation of immunosuppressive microenvironments.
- Helpless cytotoxic T lymphocytes and tumor cell evasion further complicate immune-mediated tumor destruction.
Conclusions:
- Overcoming melanoma's immune evasion strategies is essential for successful cancer vaccine development.
- Addressing factors like T-cell exhaustion and immunosuppressive microenvironments is critical for enhancing immunotherapy efficacy.
- Further research into peptide-based immunization and overcoming immunological barriers is needed to improve cancer treatment outcomes.
Related Concept Videos
01:27Tumor Immunotherapy
01:30Cancer Vaccines
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...